Detalles de la búsqueda
1.
Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status.
Dermatology;
240(1): 164-169, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37918362
2.
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
Int J Cancer;
145(2): 390-400, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613976
3.
The antiquity of hydrocephalus: the first full palaeo-neuropathological description.
Neurol Sci;
40(6): 1315-1322, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30471018
4.
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
Hum Mol Genet;
24(18): 5345-55, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26130695
5.
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Cancer;
123(2): 210-218, 2017 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27648926
6.
EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.
Breast Cancer Res Treat;
160(1): 181-186, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27628328
7.
Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications.
Oncology;
86(2): 104-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24457427
8.
SULT1A1 gene deletion in BRCA2-associated male breast cancer: a link between genes and environmental exposures?
J Cell Mol Med;
17(5): 605-7, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23711090
9.
Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies.
Breast Cancer Res Treat;
162(1): 199-200, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28091860
10.
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.
Breast Cancer Res Treat;
134(1): 411-8, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22527108
11.
Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy.
Breast Cancer Res Treat;
126(2): 539-43, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21165771
12.
Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical Relevance.
Cancers (Basel);
13(18)2021 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34572741
13.
DNA methylation-based biomarkers of aging were slowed down in a two-year diet and physical activity intervention trial: the DAMA study.
Aging Cell;
20(10): e13439, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34535961
14.
BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.
Breast Cancer Res Treat;
116(3): 577-86, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18819001
15.
MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Anticancer Res;
39(8): 4085-4093, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31366492
16.
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk.
Endocr Connect;
8(8): 1224-1229, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31336362
17.
Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers.
Oncotarget;
9(28): 19783-19792, 2018 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29731982
18.
PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report.
Clin Case Rep;
6(7): 1358-1363, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29988677
19.
Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile.
Oncotarget;
9(63): 32173-32181, 2018 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30181807
20.
Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy.
Breast;
40: 85-91, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29709729